Testing effectiveness (Phase 2)Study completedNCT02260193
What this trial is testing
16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Participants With End Stage Renal Disease (ESRD) Requiring Chronic Hemodialysis
Who this might be right for
AnemiaEnd Stage Renal Disease
Akebia Therapeutics 94